SCHEMBL31323813

SCHEMBL31323813

CN(CCCCO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)C(CCCCCOC(=O)C1CCCCCCCCCCCCCC1)CCCCCOC(=O)C1CCCCCCCCCCCCCC1

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 6/20 0.41
▸ CHRM4 P08173 6/20 0.41
▸ CHRM1 P11229 6/20 0.41
▸ CHRM3 P20309 6/20 0.41
▸ POLB P06746 1/20 0.35
▸ CYP3A4 P08684 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ FKBP1A P62942 2/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31323820 1.00 CHRM2 (0.41) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL31323874 0.92 CHRM2 (0.38) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL31323837 0.92 CHRM2 (0.38) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL31323853 0.90 CHRM2 (0.43) CHRM2CHRM4CHRM1CHRM3CYP3A4
SCHEMBL31323862 0.88 CHRM2 (0.40) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL31323958 0.87 CHRM2 (0.40) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL31323863 0.83 NAAA (0.37) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL30977718 0.83 CHRM2 (0.32) CHRM2CHRM4CHRM1CHRM3SMN1; SMN2
SCHEMBL31323821 0.83 CHRM2 (0.35) CHRM2CHRM4CHRM1CHRM3CYP3A4
SCHEMBL31323934 0.83 CHRM2 (0.35) CHRM2CHRM4CHRM1CHRM3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025035202-A1 IONIZABLE LIPIDS COMPRISING MACROCYCLIC RINGS FOR THE DELIVERY OF THERAPEUTIC AGENTS NANOVATION THERAPEUTICS INC. (CA) 2025-02-20 — — WO disclosed
Send feedback